X/2 Entry in Aarti Drugs can be taken after closing above 467 and second X/2 entry can be taken after closing above 475. Targets will be 489 and 510. Long term target in the company will be 531. Stop loss in the company can be maintained at a closing below 440. Aarti Drugs Ltd. is a manufacturer of APIs Pharma intermediates and specialty chemicals. Negative of...
NSE:AARTIDRUGS is sustained above important support level. My idea is to take buy entry at level of 455 with stop loss of 435 (-20 Points).My expected upside target will be 478 & 518. Note: This is my personal analysis, only for learning. Thanks.
It will be best to take positional buy entry on NSE:AARTIDRUGS once price reach at the level of 422. Stop Loss will be 400. My expected upside target will be 457, 510 & 529. This could be low risk and high reward option. Note: This is my personal analysis, only for learning. Thanks.
hey traders this is aarti drugs 1 day chart looks bearish will short every rise the next strong support is 380
Monthly Trend: Down Weekly Trend: Sideways Daily Trend: Sideways There is a Daily Trendline and Channel Pattern Best opportunity is going to be when stock Breaks down from the Channel or Trendline. Why will the price not go up? My view is that the price has been consolidating after being in Downtrend and is currently at Resistance and in Channel pattern. Target: 406
BUY #AARTIDRUGS STOCK PRICE @438.50 75% ROI EXPECTED Buy Entry @ 438.25 Target @ 774 Our Unique Features: ————————————————————— 1. Follow our 15 signals ….10% equity will increase in your account for sure. 2. We are not Trailing stop! or average the trades. 3. 2% Risk Management Per trade. 4. Risk vs Reward up to 1:7. Note: Trade signals would usually have a...
A inverse recovery for AARTI! Following levels can be the upcoming targets🎯!!
Market Expectation At ₹432.55, the market expects Aarti Drugs to grow profits by 12.4% per year If it grows profits by 15.4% per year, the stock should be priced at ₹488.23. current share price is 11% Undervalued Past Performance Last year, profits declined by -21.6% Profits over past 5 years grew by 26.3% per year Forecast Range from 3 Analysts To achieve the...
The chart looks bullish, the risk and reward ratio can be rewarding.
AARTIDRUGS, after giving a breakout from wedge, looking for a breakout for the a,b,c, correction. One may enter after breakout and retest by following strict stoploss. -Definitely not SEBI - Registered. So, this is only for educational purpose.
short term entry :520 target:615 use 50 ema to ride the trend
Performed very well last year. As of now it looks like it will come around 200 price range, I will buy around monthly support area. looks like it is going for a retest of support.
After a long correction in price and time too, now this stock is giving some short time buy opportunity. At least 20-30 % is possible in short time. It is just for educational purpose.
Strong Business model - good numbers due to covid.
Trading idea Buy: 545 Target: (ideal target 564) Stop loss: 536 Profit: 2109 Loss: 999 Risk/Reward: 1:2.11 Quantity: 111 Good buying volumes in the last two days
Aarti Drug 501-480 long zone... lets see if it find support there.... wait for confirmation on Reversal to long is this one ...no hurry
Medium to long term holding. Not for intraday. Like, share and subscribe.